SK Bioscience

Read more
Jaeyong Ahn's photo - CEO of SK Bioscience

CEO

Jaeyong Ahn

CEO Approval Rating

90/100

Founded:

2001

Status:

PublicSubsidiary of SK Holdings Co, LtdOther302440

Annual Revenue
<$1M
Employees
<10

SK BIOSCIENCE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

SK Bioscience's company profile
Jaeyong Ahn's photo - CEO of SK Bioscience

Jaeyong Ahn

CEO

90/100
0
$3.6M
$ < 1M
View Profile
1
SK Bioscience's Competitor - CytoAgents logo
Teresa Whalen's photo - CEO of CytoAgents

Teresa Whalen

CEO

90/100
23
$3.6M
$ < 1M
View Profile
2
SK Bioscience's Competitor - Codagenix logo
J Robert Coleman's photo - Co-Founder & CEO of Codagenix

J Robert Coleman

Co-Founder & CEO

90/100
13
$25.3M
$3.4M
View Profile
3
SK Bioscience's Competitor - CyTuVax logo
Rene Vleugels's photo - Co-Founder & CEO of CyTuVax

Rene Vleugels

Co-Founder & CEO

90/100
30
- -
$4.5M
View Profile

Missing a competitor? Contribute!

CytoAgents is one of SK Bioscience's top rivals. CytoAgents is a Private company that was founded in 2018 in Pittsburgh, Pennsylvania. CytoAgents competes in the Biotechnology industry. Compared to SK Bioscience, CytoAgents has 23 more employees.

Codagenix is seen as one of SK Bioscience's biggest rivals. Codagenix was founded in 2009 in Farmingdale, New York. Codagenix is in the Biotechnology industry. Codagenix generates $3.4M more revenue than SK Bioscience.

CyTuVax is one of SK Bioscience's top competitors. CyTuVax was founded in 2012, and its headquarters is in Maastricht, Other. Like SK Bioscience, CyTuVax also competes in the Pharmaceuticals sector. CyTuVax has 30 more employees than SK Bioscience.

SK Bioscience Quarterly and Annual Revenue

Coming soon for SK Bioscience!

Annual Revenue

SK Bioscience Acquisitions

No recent acquisitions found related to SK Bioscience

SK Bioscience Funding History

Since SK Bioscience was founded in 2001, it has participated in 2 rounds of funding. In total SK Bioscience has raised $3.6M. SK Bioscience's last funding round was on Mar 2021 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Mar 2021
--
-
Grant
May 2020
$3.6M

Since SK Bioscience was founded in 2001, it has participated in 2 rounds of funding. In total SK Bioscience has raised $3.6M. SK Bioscience's last funding round was on Mar 2021 for a total of $0

SK Bioscience Investments

No recent investments found related to SK Bioscience

SK Bioscience News

August 12, 2021PMLiVE

South Korean company SK bioscience moves into phase 3 trials for its COVID-19 vaccine

Part of the Wave 2 vaccine programme, GBP510 will bolster South Korea's domestic supply if successful... See more »
August 12, 2021The Korea Herald

SK's vaccine units, EcoPro BM join MSCI Korea index

Morgan Stanley Capital International announced Thursday that it has added three South Koreans stocks ... See more »
July 15, 2021The Korea Herald

SK Bioscience aims to launch COVID-19 vaccine by early next year

SK Bioscience is to soon begin the Phase 3 clinical trial of its COVID-19 vaccine candidate, the firm... See more »
June 22, 2021Webindia123

SK Bioscience to invest 150 billion won in vaccine factory expansion

Seoul [South Korea], June 22 (ANI/Global Economic): SK Bioscience has begun work to become a hub for ... See more »
June 21, 2021FiercePharma

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost-and looks to add mRNA to the menu

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost-and looks to add mRNA ... See more »
June 21, 2021The Korea Bizwire

SK Bioscience to Invest 150 bln Won to Beef Up Vaccine Production Capacity

SEOUL, June 21 (Korea Bizwire) - SK Bioscience Co., a major South Korean pharmaceutical firm, said Mo... See more »
May 28, 2021Biospectrum Asia

CEPI injects additional funding of $173.4 M into Korean firm SK bioscience's vaccine project

This brings CEPI's total investment in SK bioscience to $210.1 million... See more »

Social Media

SK Bioscience Headquarters

310 Pangyo-ro Bundang-gu

Seongnam, Gyeonggido13494

82-2-2008-2200

Driving Directions »

Trending Companies

SK Bioscience Summary

ABOUT

Overview

SK Bioscience is a biotechnology company that develops pharmaceutical products for the treatment of COVID-19, and influenza. SK Bioscience was founded in 2001. SK Bioscience's headquarters is located in Seongnam, Gyeonggido, KR 13494. It has raised 3....

CEO

SK Bioscience's CEO, Jaeyong Ahn, currently has an approval rating of 90%. SK Bioscience's primary competitors are CytoAgents, Codagenix & CyTuVax.

Frequently Asked Questions about SK Bioscience

  1. When was SK Bioscience founded?

    SK Bioscience was founded in 2001
  2. Who is SK Bioscience's CEO?

    SK Bioscience's CEO is Jaeyong Ahn
  3. How much revenue does SK Bioscience generate?

    SK Bioscience generates $ < 1M in revenue
  4. How much funding does SK Bioscience have?

    SK Bioscience has historically raised $3.6M in funding
  1. Where is SK Bioscience's headquarters?

    SK Bioscience's headquarters is in Seongnam Gyeonggido, KR
  2. How many employees does SK Bioscience have?

    SK Bioscience has 0 employees
  3. What sector does SK Bioscience operate in?

    SK Bioscience is in Pharmaceuticals
  4. Who are SK Bioscience's competitors?

    SK Bioscience's top competitors are CytoAgents, Codagenix, CyTuVax